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Objective: Mild cognitive impairment (MCI) in older individuals is associated with
increased risk of progression to dementia. The factors predicting progression are not
yet well established, yet cognitive performance, particularly for memory, is known to
be important. Anosognosia, meaning lack of awareness of one’s impaired function, is
commonly reported in dementia and is often also a feature of MCI, but its association
with risk of progression is not well understood. In particular, self-appraisal measures
provide an autonomous measure of insight abilities, without the need of an informant.
Methods: The present study examined the utility of self-appraisal accuracy at baseline for
predicting cognitive decline in 51 patients using an informant-free assessment method.
Baseline task performance scores were compared to self-assessments of performance
to yield a discrimination score (DS) for tasks tapping into memory and executive
functions.
Results: Linear regression revealed that a larger DS for executive function tasks in MCI
predicted functional decline, independent of age, education, and baseline memory and
executive task scores.
Conclusion: These findings indicate that objective estimates of self-appraisal can be
used to quantify anosognosia and increase predictive accuracy for decline in MCI.
Keywords: dementia, anosognosia, Alzheimer’s disease, neuropsychology, prodromal symptoms, disease
progression, neurodegeneration, cognition
INTRODUCTION
Cognitive decline is a common feature of aging (Anstey and Low, 2004; Weaver et al., 2006). In
many individuals cognitive changes represent the early signs of neurodegenerative disease that
will ultimately progress to dementia. Much of the research aimed at improving early diagnosis
of neurodegenerative disease has focused on the syndrome of mild cognitive impairment (MCI).
MCI is defined as a syndrome of cognitive change in the elderly that sometimes represents
a transitional phase between normal aging and dementia (Petersen et al., 1999; Celsis, 2000;
Collie and Maruff, 2000). Studies of patients with MCI have revealed that, among the many
potential markers predicting decline, performance on neuropsychological testing is one of the
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most powerful (Tabert et al., 2006; Albert et al., 2007; Dickerson
et al., 2007; Howieson et al., 2008; Saxton et al., 2009; Summers
and Sauders, 2012). Most of these studies have highlighted the
importance of episodic memory tasks, but several groups have
indicated that tasks tapping other domains of cognition can
improve predictive accuracy (Baudic et al., 2006; Tabert et al.,
2006; Dickerson et al., 2007; Howieson et al., 2008; Libon et al.,
2010). One domain that has received relatively little study is
metacognition, or awareness of one’s own cognitive abilities
and impairments (Eslinger et al., 2005; Spitznagel and Tremont,
2005).
Anosognosia, or awareness of one’s deficits, is a common
feature of dementia which becomes more prevalent and severe
as the illness worsens (Mullen et al., 1996; Agnew and
Morris, 1998; Zanetti et al., 1999; Vogel et al., 2005; Rosen
et al., 2010; Maki et al., 2012). Because many patients with
MCI complain about their poor memory, anosognosia is not
considered a central feature of MCI (Edmonds et al., 2014).
A number of studies, however, have demonstrated that MCI
is associated with anosognosia by using tools to compare
patients’ assessments of their own abilities with appraisals of
knowledgeable informants. Such methods have demonstrated
that some MCI patients overestimate their cognitive abilities
(Albert et al., 1999; Tabert et al., 2002; Vogel et al., 2004, 2005).
Furthermore, studies using these informant based methods
have demonstrated that anosognosia in MCI is associated
with an increased risk of decline on longitudinal follow-up
(Tabert et al., 2002; Edmonds et al., 2014). These findings
are supported by other studies indicating that informant
reports are more predictive of cognitive decline in MCI
compared with self-report (Tierney et al., 1996; Gifford et al.,
2014). Taken together, these data indicate that measurement
of anosognosia in MCI is useful for predicting decline to
dementia.
Methods for quantifying anosognosia vary. While most
studies compare self-report to informant reports, it is
possible to compare a person’s appraisal of their abilities
to objective measurements based on neuropsychological
testing (Clare, 2004; Clare et al., 2004; Williamson et al.,
2010; Rosen, 2011). These methods have potential advantages
over informant-based measures due to additional factors
which might influence informant estimates, including the
informant’s familiarity with the patient as well as their
own cognitive function and emotional states. Additionally,
knowledgeable and reliable informants may not be available
in many clinical and research settings. At least two studies
have demonstrated anosognosia in MCI without the use of
informants (Rosen et al., 2010; Krueger et al., 2011); however,
it has yet to be demonstrated whether such impairment
predicts decline to dementia. The goal of this analysis
was to evaluate the utility of neuropsychologically-based
measurements of self-appraisal to predict cognitive decline
in MCI on longitudinal follow-up. Because memory is a
known predictor of cognitive decline in MCI, we wished to
establish whether self-appraisal of impairments had value
beyond what would be predicted by baseline memory scores.
We thus included two memory assessments in our analysis:
one to predict decline based on memory-task performance
and the second to predict decline based on memory self-
appraisal. In addition, because deficits in MCI may include
multiple domains of cognition, especially in executive
functioning processes such as attention, planning and judgment
(Traykov et al., 2007; Brandt et al., 2009; Gomar et al., 2011;
Johns et al., 2012), we evaluated self-appraisal for executive
performance.
MATERIALS AND METHODS
Participants
Subjects were recruited from a larger study of MCI, the goal
of which was to identify risk factors for decline. The self-
appraisal tasks were added part-way through the recruitment
phase, and were administered to all enrollees from this point
when time permitted. The study began recruitment in 2003
and participants in the study were followed for an average
of about 3 years. Participants were referred to the study by
memory clinics in the San Francisco Bay Area, including the
Memory Disorders Clinic at the San Francisco Veterans Affairs
Medical Center, the Memory and Aging Center (MAC) at
the University of California, San Francisco, and the Memory
Disorders Clinic at the California Pacific Medical Center or
recruited by flyers and advertisements in local newspapers.
Participants were required to have an informant who knew
them well and could answer questions about their cognition
and general health. Exclusion criteria included any medical,
psychiatric, or neurologic condition (other than MCI) that
could significantly affect brain structure or cognition. All data
included in this manuscript was obtained in compliance with
UCSF CHR system and written informed consent was in
accordance with the Declaration of Helsinki and UCSF CHR
system.
The larger study enrolled both cognitively normal participants
and those with MCI. MCI was operationally defined MCI
according to published guidelines (Petersen, 2004; Winblad
et al., 2004). To capture the broadest range of MCI, we did
not require that subjects perform below specific cutoffs on
psychometric testing because we were interested in including
individuals at the mildest end of the MCI spectrum (i.e., those
with Clinical Dementia Rating (CDR) sum of boxes scores
0.5–1). If cognitive testing did not reveal significant impairment
(>1.5 standard deviations below age-matched norms), both the
participant and informant had to endorse subjective cognitive
decline. Healthy controls (HC) were defined as those having a
CDR of 0. Since we aimed to assess the relationship between
self-appraisal at baseline and subsequent decline, we included
individuals who had a diagnosis of MCI at baseline as well
as those diagnosed as cognitively HC (non-controls, NC) at
baseline who subsequently declined to the point of MCI or
dementia on longitudinal follow-up. We were able to identify
51 individuals (ALLsample) meeting these criteria in whom the
self-appraisal task had been administered, including nine NC and
42 MCI at baseline. At final assessment, seven NC received a
new diagnosis of MCI, two NC were diagnosed with dementia
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(1 Alzheimer’s disease, AD; 1 behavioral variant frontotemporal
dementia, bvFTD), 22 MCI maintained a diagnosis of MCI, and
20 MCI progressed to AD. Overtime, 29 participants underwent
a change in clinical diagnosis and 22 maintained an MCI
diagnosis.
Neuropsychological and Functional
Assessment
All participants completed a battery of standardized assessments
including: the Mini-Mental State Examination (MMSE, Folstein
et al., 1975), modified Trails (Number, Letter, Switching
between numbers and letter; Kramer et al., 2003), Stroop
(Color naming, Word naming, Inhibition, Switch; Delis
et al., 2001), Wechsler Memory Scale, immediate and verbal
delayed recall (WMS; Wechsler, 1997), and the California
Verbal Learning Test-2nd Edition (CVLT-2; Delis et al.,
2000) long delayed free recall (Ldfr) and recognition (Rgn).
The CDR Morris, 1993) was used to quantify functional
impairment.
Self-Appraisal
Self-appraisal accuracy was evaluated by comparing self-ratings
to actual performance for the modified Trails switch condition,
Stroop switch condition and WMS long delay tasks (see
‘‘Analysis’’ Section for creation of accuracy scores). The
CVLT-2 was not used for self-appraisal as it was used
as an independent memory performance score to predict
decline. At the beginning of the testing session, patients
were informed that they would be asked to rate their
performance compared to what they would expect to be
average performance. They were reminded that on most
tasks the majority of people would score in the average
range, at 50th percentile, while fewer individuals would have
much higher or much lower scores than average. A picture
of a bell curve was provided as a visual aid, with labels
corresponding to percentile rankings ranging from 1 to 99
(Figure 1). This method has been used to assess self-
appraisal in adults with neurodegenerative disease (Rosen et al.,
2010; Williamson et al., 2010) and cognitive impairment due
to HIV (Chiao et al., 2013) as well as in children with
FIGURE 1 | Picture of the bell curve provided as a visual aid for the self-appraisal component of assessment, with labels corresponding to percentile
rankings ranging from 1 to 99. Prior to the memory and executive tasks, participants were informed that they were going to do a post-task performance
assessment, rating themselves on the task compared to what they would expect to be average performance. In addition, they were consistently reminded that on
most tasks the majority of people would score in the average range, at 50th percentile, while fewer individuals would have much higher or much lower scores than
average.
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cognitive impairment (Krueger et al., 2011). Self-assessment was
only requested after completion of each task, because other
studies have shown that prediction of performance on typical
neuropsychological tasks is poor even in normal adults (Eslinger
et al., 2005).
Analysis (Figure 2)
Self-appraisal was measured for both executive function and
episodic memory at the baseline testing session. For each
of these tasks, a discrimination score (DS) was computed
by subtracting actual performance (Pr) from self-appraised
performance (SAPr): DS = SAPr-Pr. The WMS long delay
recall score was used to create the memory DS score
(memDS). A composite DS for executive function (execDS)
was created using the mean DS from the switch subtests of
the Trails and Stroop tasks. Because the DS is calculated
based on actual performance, it is important to control
for this performance to accurately assess the effect of self-
appraisal. In theory, if all subjects rated themselves as exactly
average, then the variability in DS would only represent
variability in performance and not self-appraisal. To control
for memory performance (memPr), we used the CVLT-2 Ldfr
score. To control for executive function performance, we used
an executive function composite score (execPr) created by
averaging the scores from the remaining five executive subtests
(Stroop color, number and inhibition; Trails number and
letter).
The CDR ‘‘sum of boxes’’ (CDRsb), measured at each
testing session, provided an index of functional impairment,
where a higher number represents larger burden. The outcome
variable of interest was functional change over time as measured
by change in the CDRsb score. This was used instead of
likelihood of conversion to dementia in order to capture
progressive decline in function not severe enough to merit
a diagnosis of dementia. Change in CDRsb (∆CDRsb) was
calculated for each patient by subtracting the score at baseline
from the score at the last assessment. Because the duration
of follow-up varied across individuals, a correction factor
for time was applied (∆CDRcorr= ∆CDR/number of years
between assessments) to create an annualized rate of decline for
CDRsb.
Statistical analyses were computed using SPSS (version
22.0; SPSS/IBM, Chicago, IL, USA). Normality for individual
variables was determined by the Shapiro–Wilk test. Distributions
were normal for all variables except for the ∆CDRcorr. A
natural log transform was applied to normalize this data. A
multivariate linear regression examined the relationship between
the potential predictors, including memDS, memPr, execDS,
execPr scores, and the outcome ∆CDRcorr, with age and
education included as additional covariates. Added variance
contributed by the main factors of interest, execDS and memPr
scores, were examined through separate stepwise multivariate
linear regression analyses.
RESULTS
Baseline descriptive statistics, ∆CDRcorr and
neuropsychological testing data are presented in Table 1.
FIGURE 2 | (1) Diagnosis breakdown for the ALLsample at Baseline and Final testing sessions (Note: Final box indicates conversions from baseline status);
NC, normal controls; MIC, mild cognitive impairment; AD, Alzheimer’s disease; bvFTD, behavioral variant frontotemporal dementia. (2) Components making up the
regression model (Pr, performance; SAPr, Self assessment of performance; DS, Discrimination score). (A) Memory component of the model, with DS and Pr control
scores; (B) Executive component of the model, with DS and Pr control scores; (C) Impairment index corrected for the variable times between baseline and final
diagnosis; (D) Other important variables in the model, including Age at baseline assessment and Education level (# of years).
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TABLE 1 | Mean values for the “ALL” cohort (n = 51).
Age Education Sex Test Years MMSE ∆CDRcorr execPr execDS memPr memDS
Mean 75.80 17.02 35M/16F 3.00 28.39 0.81 55.24 15.72 41.31 −2.16
Standard deviation 7.16 2.66 — 1.87 1.66 0.87 22.95 32.19 36.13 32.62
Min/Max 55/89 8/22 — 0.72/7.45 0.07/1.49 0.50/6.50 2.60/92.60 −46.5/81.50 0.00/99.00 −75/88
Age = age of participant at baseline; Education = years; Test Years = years between the baseline and final testing session; MMSE, Mini Mental State Examination; 1CDR,
Change in CDR sb (final − baseline); 1CDRcorr = annual rate of decline of 1CDR; execPr = Actual task performance on executive tasks (Stroop: color, word, inhibition;
Trails: number, letter); execDS = discrimination score for executive tasks (Stroop and Trails: switch subtests); memPr = actual task performance (CVLT-2 delayed recall);
memDS = memory discrimination score (WMS verbal delayed recall).
As would be expected based on prior characterization of
MCI, performance in this group was worse for memory (41st
percentile) than for executive function (55th percentile). On
average, patients tended to self-rate their memory performance
as poor, as indicated by a slightly negative memDS (−2.16
percentile points), but over-rated their executive function
performance at 15.7 percentile points better than their actual
performance.
Linear regression using six predictors (execDS, execPr,
memDS, memPr, age and education) in the ALLsample
(n = 51) accounted for 25.5% of the variance in functional
decline, F(6,44) = 3.847, p = 0.004, R2 = 0.344, R2
adjusted = 0.255, 90% CI [−7.482, −1.944]. Both memPr
and execDS scores were independent predictors of decline.
MemPr (or CVLT-2 scores) was inversely related to decline
(lower score, more decline), while execDS was positively
correlated with decline, indicating that those who rated
themselves best relative to their actual performance showed
more decline (Table 2A). Stepwise regressions indicate that
memPr scores explain 11% and ExecDS contributes to 6.7%
of the total model variance, calculated using the Adjusted
R2 values.
Furthermore, we considered the possibility that including
individuals who started as NC but declined over time could
detract from the clinical relevance of the analysis. Such patients
would not be identified in a clinic as having a potential
neurodegenerative disease, and thus the question of what predicts
decline in them would not come up in practice. Thus, we
repeated the regression analysis with only those who began
the study with an MCI diagnosis (MCIonly, n = 42). The
results were similar, with the overall model accounting for
19.3% of the variance in functional decline, F(6,35) = 2.636,
p = 0.032, R2 = 0.311, R adjusted = 0.193, 90% CI [−9.304,
−0.845]. Again, both memPr and execDS were independent
predictors of decline (Table 2B). Stepwise regressions in the
MCIonly cohort uncovered individual variance in the larger
model for memPr and ExecDS scores, explaining 11.9% and
8.8%, respectively.
TABLE 2 | Multiple regression analysis on log transformed ∆CDRcorr.
Zero-order Standard t Significant 90% CI 90% CI
correlations coefficients beta lower upper
(R) (R2) Adjusted R2 (F) Significant
A. “ALL” cohort (n = 51)
(Constant) −2.860 0.006 −7.482 −1.944
Exec_Pr −0.258 0.107 0.581 0.564 −0.008 0.017
Exec_DS 0.336 0.415 2.245 0.030 0.003 0.021
Memory_Pr −0.375 −0.372 −2.758 0.008 −0.016 −0.004
Memory_DS 0.124 −0.123 −0.888 0.380 −0.010 0.003
Age 0.343 0.259 2.008 0.051 0.006 0.063
Education 0.080 0.239 1.849 0.071 0.008 0.162
Total model 0.587 0.344 0.255 3.874 0.004
B. “MCIonly” cohort (n = 42)
(Constant) −2.436 0.020 −9.304 −0.845
Exec_Pr −0.2240 0.221 0.958 0.345 −0.010 0.028
Exec_DS 0.301 0.510 2.219 0.033 0.001 0.029
Memory_Pr −0.348 −0.408 −2.511 0.017 −0.022 −0.002
Memory_DS 0.149 −0.164 −0.968 0.340 −0.015 0.005
Age 0.291 0.263 1.1729 0.093 0.007 0.084
Education 0.087 0.192 1.314 0.197 −0.038 0.179
Total model 0.558 0.311 0.193 2.636 0.032
Age = age of participant at baseline; Education = years; 1CDRcorr = annual rate of decline of 1CDR; execPr = Actual task performance on executive tasks (Stroop: color,
word, inhibition; Trails: number, letter); execDS = discrimination score for executive tasks (Stroop and Trails: switch subtests); memPr = actual task performance (CVLT
delayed recall); memDS = memory discrimination score (WMS verbal delayed recall). ∗significant at p < 0.05.
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DISCUSSION
The present study used an objective neuropsychologically-
based assessment battery along with an informant-free,
subjective self-appraisal task to demonstrate that reduced
insight into performance abilities at baseline predicts a
larger degree of functional decline in MCI. The findings
were specific to executive function and were independent
of other variables of interest including age, education,
executive task performance, memory task performance and
self-appraisal of memory abilities. The results suggest that
objective estimates of self-appraisal in patients themselves,
using defined ranking measurements, could be used to quantify
anosognosia and increase predictive accuracy for decline in
MCI.
Our finding that baseline self-appraisal impairment predicts
a higher likelihood of decline in MCI is consistent with
prior studies demonstrating that patients with MCI tend to
overestimate their skills (Tierney et al., 1996; Albert et al., 1999;
Vogel et al., 2004; Orfei et al., 2010), and that the discrepancy
between the ratings of the patient and those of informants
is predictive of decline to AD. A recent study of MCI in
the Alzheimer’s Neuroimaging Initiative came to a similar
conclusion when they found that the informant estimate of a
patient’s function is more valuable than the patient’s estimate
in predicting decline. Underestimating one’s function has also
been found to be associated with cerebrospinal fluids (CSF)
markers indicating AD (Edmonds et al., 2014). The majority
of studies examining anosognosia in MCI, including all those
looking at predictors of decline, have used informant or
caregiver accounts of patient abilities. The approach taken
in the current analysis has potential advantages in that it
can be used when an informant is not available and does
not depend on the informant to ‘‘notice’’ sometimes subtle
changes in the patient. Additionally, a task-based protocol
with immediate self-assessment questions permits cognitive-
domain specificity, limiting overgeneralization of abilities when
self-appraisals are only collected at the end of a lengthy
testing session. A possible disadvantage of this technique is
potential loss of validity in more cognitively impaired patients
who may have difficulty understanding or remembering the
instructions to rate oneself in terms of percentile. This is less
of a concern in MCI patients, whose cognitive dysfunction
is mild compared with dementia patients. In theory, the
concept of percentile rankings may be impacted by education,
but it should be noted that we considered education in the
multiple regression analysis and we have previously used this
method in children as young as 12 and identified relationships
with teacher/parent behavioral ratings (Krueger et al., 2011).
Further studies in adults with varying levels of education
would be helpful in establishing the generalizability of this
approach.
Memory impairments are considered to be one of the
first reported deficits in MCI and AD patients, yet executive
changes are known to be affected in progressed dementia
and considered to be among the earliest cognitive changes
in AD (Wilson et al., 1983; Storandt and Hill, 1989; Albert,
1996; Dickerson et al., 2007). Decreased performance on
similar executive tasks have been shown to be predictors
of progressively diminishing functional abilities over time
(older vs. young adults: Spieler et al., 1996; healthy elderly
vs. mild AD: Castel et al., 2007; APOE-4 status MCI vs.
non-APOE MCI: Albert, 1996). Such executive tasks require
large frontal contributions for successful completion (Trails:
Ettlin et al., 2000; Stuss et al., 2001; Stroop: Peterson et al.,
2002; Ridderinkhof, 2002; De Pisapia and Braver, 2006) a
region also reported as showing atrophy or hypometabolism
in patients with dementia (Rahman et al., 1999; Snowden
et al., 2002). Similarly, previous work has indicated that insight
impairments are also a likely a function declining frontal lobe
integrity (Mendez and Shapira, 2005; Mimura and Yano, 2006;
Salmon et al., 2006; Rosen et al., 2010; Williamson et al.,
2010).
Our study found that self-appraisal for executive function,
but not memory function, predicted decline. This makes sense
considering that the most common complaint in MCI patients
is memory impairment. This was evident in our cohort, where
initial memory performance was low (41st percentile) and
the discrepancy between actual performance and self-appraisal
was only 2 percentile points. In contrast, executive function
was in the average range in the group as a whole, but
the discrepancy was much larger (15 percentile points). This
indicates that the patients were sensitive to their memory
decline, but overestimated their executive function capabilities
(some to a very high degree). This raises the possibility
that the brain’s capacity for self-monitoring is not equal
for all domains of cognition. Memory monitoring may be
intrinsically stronger than monitoring of executive function,
which may partly explain why memory complaints are among
the most common in aging as well as MCI (Busse et al.,
2006; Albert et al., 2007; Dickerson et al., 2007). Indeed,
prior studies have suggested that self-monitoring varies across
domains of neurological function (McGlynn and Schacter,
1989).
Some notable limitations warrant discussion. The small
sample size of ‘‘converted’’ patients, who received a clinical
diagnosis of dementia over time, restricted power to compute
our multifactorial comprehensive multiple-regression analysis
on this specific cohort. However, with a conversion rate
of 16% in our longitudinal sample, this is comparable to
general MCI to AD conversion rates (10–15%; Caroline, 2008;
Mridula et al., 2008). In addition, race and sex biases are
also potential limitations, with a 94% Caucasian population
and a 2–1 male dominated cohort. The latter sex difference
warrants further study in MCI and dementia cohorts, since
previous studies in healthy samples have shown that men tend
to inflate self-judgments of task ability compared to women,
even when performing on the same level (Mengelkamp and
Jäger, 2007). Finally, the voluntary recruitment nature of our
sample and the affiliation with a ‘‘memory’’ clinic lead to
a pre-selection bias in this patient cohort. These patients
are more aware of personal cognitive impairments, leading
to seek clinical help and participate in such studies. The
contributing values of insight deficits presented in this article
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are likely underestimated and worse in the general affected
population.
Overall, while previous research has suggested measures of
memory as a sensitive measure of MCI deficits and likelihood of
progression, self-appraisal deficits related to executive capacities
may be more sensitive, particularly early in disease progression.
This latter point is important in prodromal forms of dementia,
such as MCI. Intrinsic variation in self-monitoring abilities
across domains may make executive function a more sensitive
target for detecting self-appraisal impairments indicating more
severe disease or greater likelihood of cognitive decline. In
addition, it is possible that domain-specificity in self-appraisal
has other important implications; for instance, it may be a better
marker of functional impairment. The ability to assess domain-
specific self-appraisal in a well-defined manner is another
potential advantage for neuropsychologically-based approaches
compared with informant based approaches for measuring
anosognosia. For this reason, as well as others discussed above,
we believe that these approaches should be used more frequently
in formal cognitive assessments of patient cohorts with possible
progressive disease burden, such as MCI.
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